Azathioprine-associated myelodysplastic syndrome with cytogenetic abnormalities;Azathioprin-assoziiertes myelodysplastisches syndrom mit zytogenetischen aberrationen

Deutsche Medizinische Wochenschrift

Volumn 129, Issue 22, 2004, Pages 1246-1248

  Willerding Mollmann S ^a   Wilkens, L ^b   Schlegelberger, B ^b   Kaiser, U ^a  

^a ST BERNWARD KRANKENHAUS   (Germany)

^b HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; HEMOGLOBIN; IMMUNOSUPPRESSIVE AGENT;

ADULT; ALLOTRANSPLANTATION; ARTICLE; BLEEDING; CASE REPORT; CHROMOSOME 7; CLINICAL FEATURE; CYTOGENETICS; DISEASE COURSE; FATIGUE; FEMALE; HEMATOLOGY; HUMAN; MULTIPLE SCLEROSIS; MYELODYSPLASTIC SYNDROME; PANCYTOPENIA; SIDE EFFECT; SUBDURAL HEMATOMA; TACHYCARDIA; THROMBOCYTE TRANSFUSION; THROMBOCYTOPATHY; WORLD HEALTH ORGANIZATION; ANEMIA; BONE MARROW; BONE MARROW EXAMINATION; CHEMICALLY INDUCED DISORDER; CHROMOSOME 5; CHROMOSOME ABERRATION; DRUG EFFECT; FATALITY; FLUORESCENCE IN SITU HYBRIDIZATION; GENETICS; KARYOTYPING; MIDDLE AGED; PATHOLOGY; SINUS TACHYCARDIA;

ANEMIA; AZATHIOPRINE; BONE MARROW; BONE MARROW EXAMINATION; CHROMOSOME ABERRATIONS; CHROMOSOMES, HUMAN, PAIR 5; CHROMOSOMES, HUMAN, PAIR 7; FATAL OUTCOME; FATIGUE; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; IN SITU HYBRIDIZATION, FLUORESCENCE; KARYOTYPING; MIDDLE AGED; MULTIPLE SCLEROSIS; MYELODYSPLASTIC SYNDROMES; PANCYTOPENIA; TACHYCARDIA, SINUS;

EID: 18244417577     PISSN: 00120472     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2004-826853     Document Type: Article

References (9)

1. Arnold JA, Ranson SA, Abdalla SH. Azathioprine-associated acute myeloid leukemia with trilineage dysplasia and complex karyotype: a case report and review of the literature. Clin Lab Haem 1999; 21: 289-292
2. Bloomfiled CD, Archer KJ, Mrozek K et al. 11q23 balanced chromosome aberrations in treatment-related myelodysplastic syndromes and acute leukemia: report from an international workshop. Genes Chromosomes Cancer 2002; 33: 362-378
3. Cobau CD, Sheon RP, Kirsner AB. Immunosuppressive drugs and acute leukemia. Annals of Internal Medicine 1973; 79: 131-132
4. Greenberg PL, Young NS, Gattermann N. Myelodyplastic Syndromes. Washington, American Society of Hematology, In: JL Bajus, editor. Hematology 2002. 2002: 136-161
5. Kwong YL, Au WY, Liang RHS. Acute myeloid leukemia after azathioprine treatment for autoimmune diseases: association with -7/7q-. Cancer Genet Cytogenet 1998; 103: 94-97
6. Le Beau M, Albain KS, Larson RA et al. Clinical and cytogenetic correlations in 63 patients with therapy-related myelodysplastic syndromes and acute nonlymphocytic leukemia: further evidence for characteristic abnormalities of chromosomes no. 5 and 7. J Clin Oncol 1986; 4: 325-345
7. Leone G. Therapy related leukemias: Ssusceptibility, Pprevention and treatment. Leukemia and Lymphoma 2001; 41: 255-276
8. Smith SM, Le Beau MM, Huo D et al. Clinical-cytogenetic associations in 306 patients with therapy-related myelodysplasia and myeloid leukemia: the University of Chicago series. Blood 2003; 102: 43-52
9. Zhang Y, Poetsch M, Weber-Matthiesen K et al. Secondary acute leukaemias with 11q23 rearrangement: clinical, cytogenetic, FISH and FICTION studies. Br J Haematol 1996; 92: 673-680